抗covid - 19疫苗成功的早期贡献者

Q2 Medicine
Brian Heap
{"title":"抗covid - 19疫苗成功的早期贡献者","authors":"Brian Heap","doi":"10.1016/j.medidd.2021.100105","DOIUrl":null,"url":null,"abstract":"<div><p><em>The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’</em> <span>[1]</span><em>. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine</em>.</p></div>","PeriodicalId":33528,"journal":{"name":"Medicine in Drug Discovery","volume":"12 ","pages":"Article 100105"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medidd.2021.100105","citationCount":"0","resultStr":"{\"title\":\"Early contributors to the success of anti-COVID vaccines\",\"authors\":\"Brian Heap\",\"doi\":\"10.1016/j.medidd.2021.100105\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><em>The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’</em> <span>[1]</span><em>. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine</em>.</p></div>\",\"PeriodicalId\":33528,\"journal\":{\"name\":\"Medicine in Drug Discovery\",\"volume\":\"12 \",\"pages\":\"Article 100105\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.medidd.2021.100105\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine in Drug Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590098621000269\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine in Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590098621000269","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

格雷戈里·格雷戈里亚迪斯(Gregory Gregoriadis)的论文将“个别技术从研究中脱颖而出、找到市场机会并产生切实影响”所需的时间对比清晰地展现出来。这篇简短的评论强调了一些早期事件,这些事件为新型抗covid - 19疫苗的成功奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Early contributors to the success of anti-COVID vaccines

The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicine in Drug Discovery
Medicine in Drug Discovery Medicine-Pharmacology (medical)
CiteScore
8.30
自引率
0.00%
发文量
30
审稿时长
21 days
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信